|
1
|
Arnold M, Laversanne M, Brown LM, Devesa
SS and Bray F: Predicting the future burden of esophageal cancer by
histological subtype: International trends in incidence up to 2030.
Am J Gastroenterol. 112:1247–1255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mao A: Interventional therapy of
esophageal cancer. Gastrointest Tumors. 3:59–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sunpaweravong S, Ruangsin S,
Laohawiriyakamol S, Mahattanobon S and Geater A: Prediction of
major postoperative complications and survival for locally advanced
esophageal carcinoma patients. Asian J Surg. 35:104–109. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schneider MA, Christopoulos P, Muley T,
Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller
NS, Theis F and Meister M: AURKA, DLGAP5, TPX2, KIF11 and CKAP5:
Five specific mitosis-associated genes correlate with poor
prognosis for non-small cell lung cancer patients. Int J Oncol.
50:365–372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang H, Zhang T, You Z and Zhang Y:
Positive surgical margin, HPV persistence, and expression of both
TPX2 and PD-L1 are associated with persistence/recurrence of
cervical intraepithelial neoplasia after cervical conization. PLoS
One. 10:e01428682015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao X, Sun S, Zeng X and Cui L:
Expression profiles analysis identifies a novel three-mRNA
signature to predict overall survival in oral squamous cell
carcinoma. Am J Cancer Res. 8:450–461. 2018.PubMed/NCBI
|
|
7
|
Chang H, Wang J, Tian Y, Xu J, Gou X and
Cheng J: The TPX2 gene is a promising diagnostic and therapeutic
target for cervical cancer. Oncol Rep. 27:1353–1359.
2012.PubMed/NCBI
|
|
8
|
Jiang T, Sui D, You D, Yao S, Zhang L,
Wang Y, Zhao J and Zhang Y: MiR-29a-5p inhibits proliferation and
invasion and induces apoptosis in endometrial carcinoma via
targeting TPX2. Cell Cycle. 17:1268–1278. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu CY, Qin MB, Tan L, Liu SQ and Huang JA:
NIBP impacts on the expression of E-cadherin, CD44 and vimentin in
colon cancer via the NF-κB pathway. Mol Med Rep. 13:5379–5385.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fu ZH, Liu SQ, Qin MB, Huang JA, Xu CY, Wu
WH, Zhu LY, Qin N and Lai MY: NIK and IKKβ binding protein
contributes to gastric cancer chemoresistance by promoting
epithelial mesenchymal transition through the NFκB signaling
pathway. Oncol Rep. 39:2721–2730. 2018.PubMed/NCBI
|
|
11
|
Cheng C, Zhou Y, Li H, Xiong T, Li S, Bi
Y, Kong P, Wang F, Cui H, Li Y, et al: Whole-genome sequencing
reveals diverse models of structural variations in esophageal
squamous cell carcinoma. Am J Hum Genet. 98:256–274. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Liu S, Wang H, Yang W, Li F, Yang
F, Yu D, Ramsey FV, Tuszyski GP and Hu W: Elevated NIBP/TRAPPC9
mediates tumorigenesis of cancer cells through NFκB signaling.
Oncotarget. 6:6160–6178. 2015.PubMed/NCBI
|
|
13
|
Phillips WA, Russell SE, Ciavarella ML,
Choong DY, Montgomery KG, Smith K, Pearson RB, Thomas RJ and
Campbell IG: Mutation analysis of PIK3CA and PIK3CB in esophageal
cancer and Barrett's esophagus. Int J Cancer. 118:2644–2646. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao HH, Zhang SY, Shen JH, Wu ZY, Wu JY,
Wang SH, Li EM and Xu LY: A three-protein signature and clinical
outcome in esophageal squamous cell carcinoma. Oncotarget.
6:5435–5448. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davis JN, Medbery C, Sharma S, Pablo J,
Kimsey F, Perry D, Muacevic A and Mahadevan A: Stereotactic body
radiotherapy for centrally located early-stage non-small cell lung
cancer or lung metastases from the RSSearch(®) patient
registry. Radiat Oncol. 10:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yodying H, Matsuda A, Miyashita M,
Matsumoto S, Sakurazawa N, Yamada M and Uchida E: Prognostic
significance of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in oncologic outcomes of esophageal
cancer: A systematic review and meta-analysis. Ann Surg Oncol.
23:646–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi YL, Takeuchi K, Soda M, Inamura K,
Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, et
al: Identification of novel isoforms of the EML4-ALK transforming
gene in non-small cell lung cancer. Cancer Res. 68:4971–4976. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Liu Z, Dou C, Han S, Li C, Tu K
and Yang W: miR-491 inhibits the proliferation, invasion and
migration of hepatocellular carcinoma cell via down-regulating TPX2
expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 32:512–517.
2016.(In Chinese). PubMed/NCBI
|
|
20
|
Sasaki N, Morisaki T, Hashizume K, Yao T,
Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka
M and Katano M: Nuclear factor-kappaB p65 (RelA) transcription
factor is constitutively activated in human gastric carcinoma
tissue. Clin Cancer Res. 7:4136–4142. 2001.PubMed/NCBI
|
|
21
|
Hsu PK, Chen HY, Yeh YC, Yen CC, Wu YC,
Hsu CP, Hsu WH and Chou TY: TPX2 expression is associated with cell
proliferation and patient outcome in esophageal squamous cell
carcinoma. J Gastroenterol. 49:1231–1240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu HC, Zhang Y, Wang XL, Qin WS, Liu YH,
Zhang L and Zhu CL: Upregulation of the TPX2 gene is associated
with enhanced tumor malignance of esophageal squamous cell
carcinoma. Biomed Pharmacother. 67:751–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu HC, Zhang GH, Liu YH, Wang P, Ma JF,
Su LS, Li SL, Zhang L and Liu JW: TPX2 siRNA regulates growth and
invasion of esophageal cancer cells. Biomed Pharmacother.
68:833–839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pazarentzos E and Bivona TG: Adaptive
stress signaling in targeted cancer therapy resistance. Oncogene.
34:5599–5606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin M and Liu S, Li A, Xu C, Tan L, Huang
J and Liu S: NIK- and IKKβ-binding protein promotes colon cancer
metastasis by activating the classical NF-κB pathway and MMPs.
Tumour Biol. 37:5979–5990. 2016. View Article : Google Scholar : PubMed/NCBI
|
